Subscribe To
Big call buying in this mega cap pharma stock
(OPTIMIZED VIDEO SPECIFIC DESCRIPTION) » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeC...
June 6, 2022, 2:28 pm
Fsd pharma submits ind applications to the fda and health canada for phase 2 clinical trial of fsd-201 to treat an inflammatory disorder
FSD Pharma (CSE:HUGE, NASDAQ:HUGE) Inc has announced that it has submitted Investigation New Drug applications to the US Food and Drug Administration...
May 31, 2022, 10:26 am
Why verrica pharma shares are plunging today
The FDA has issued a Complete Response Letter (CRL) regarding Verrica Pharmaceuticals Inc's (NASDAQ: VRCA) marketing application for VP-102 for mo...
May 25, 2022, 6:56 am
Immupharma says it is in talks with partners for key assets as it hails progress made last year
ImmuPharma PLC (AIM:IMM, OTC:IMMPF) hailed its recent progress as it said major roadblocks to clinical progress had been effectively cleared. In an ...
May 25, 2022, 2:48 am
Okyo pharma successfully closes us$2.5mln us fundraise
Okyo Pharma Ltd (LSE:OKYO, OTCQB:EMMLF) has confirmed it has successfully closed a US$2.5mln US fundraiser. The group, which is developing a treatment...
May 20, 2022, 2:25 am
Why zealand pharma shares are rising
Zealand Pharma A/S - ADR (NASDAQ: ZEAL) shares are trading higher by 17.01% at $13.69 after the company announced the results from its phase 3 trial o...
May 19, 2022, 10:41 am
Innate pharma sa (ipha) ceo mondher mahjoubi on q1 2022 results - earnings call transcript
Innate pharma sA (NASDAQ:IPHA ) Q1 2022 Earnings Conference Call May 10, 2022 8:00 AM ET Company Partic...
May 14, 2022, 11:08 am
Erytech pharma s.a. (eryp) ceo gil beyen on q1 2022 results - earnings call transcript
ERYTECH pharma s.A. (NASDAQ:ERYP ) Q1 2022 Earnings Conference Call May 13, 2022 8:30 AM ET Company Par...
May 13, 2022, 11:18 am
Japan's takeda pharma says full-year profit slid 9.5%
Takeda Pharmaceutical Co said on Wednesday that 12-month operating profit slid 9.5% from the previous year....
May 11, 2022, 2:20 am
International flavors (iff) q1 earnings top estimates, view up
International Flavors' (IFF) Q1 top line gains from solid growth in Health & Biosciences, Nourish and pharma s...
May 10, 2022, 1:33 pm
Connect biopharma stock plunges as ulcerative colitis candidate flunks in mid-stage study
Connect Biopharma Holdings Limited (NASDAQ: CNTB) announced topline results at 12 weeks from its Phase 2 trial for CBP-307 (CBP-307CN002) for ulcer...
May 4, 2022, 7:54 am
Immupharma says phase iii trial preparations are underway
ImmuPharma PLC (AIM:IMM, OTC:IMMPF) said preparations are being made to get an international phase III trial of its lupus drug underway after successf...
May 4, 2022, 2:35 am
Innate pharma announces conference call and webcast for q1 2022 business update
MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate pharma sA (Euronext Paris: IPH; Nasdaq: IPH...
May 3, 2022, 1:00 am
Why first wave biopharma shares are tanking today
First Wave BioPharma Inc (NASDAQ: FWBI) shares are plummeting after the company reported topline data from Phase 2 RESERVOIR trial of FW-COV, oral fo...
May 2, 2022, 8:05 am
Glaxosmithkline sales bounce higher after covid boost
GlaxoSmithKline has confirmed its total dividend this year will be cut by 35% following the demerger of its consumer healthcare arm Haleon. Alongside ...
April 27, 2022, 3:22 am
Why erytech pharma are shares moving higher today
Erytech pharma sA (NASDAQ: ERYP) has sold its US manufacturing facility to Catalent Inc (NYSE: CTLT)...
April 25, 2022, 7:15 am
Ampio pharma shares fall as fda rejects proposed change in knee osteoarthritis trial
Ampio Pharmaceuticals Inc (NYSE: AMPE) received written responses from the FDA pursuant to a Type C meeting request regarding the AP-013 Phase 3 tria...
April 21, 2022, 6:29 am
Why antares pharma stock is soaring today
Antares Pharma Inc (NASDAQ: ATRS) shares are trading higher Wednesday after the company announced it will be acquired by Halozyme Therapeutics Inc (N...
April 13, 2022, 10:47 am
Antares pharma stock rockets after halozyme buyout deal for a near-50% premium
Shares of Antares Pharma Inc. ATRS, -0.27% rocketed 46.3% in premarket trading Wednesday toward a two-decade high, after the specialty pharmaceutical ...
April 13, 2022, 6:12 am
Inozyme pharma starts dosing in inz-701 trial for calcification disorders
Inozyme Pharma Inc (NASDAQ: INZY) has dosed the first patient in its Phase 1/2 trial of INZ-701 in adult patients with ABCC6 Deficiency. Also, the ...
April 12, 2022, 11:08 am